http://www.cnr.it/ontology/cnr/individuo/prodotto/ID16167
Virtual screening-driven identification of human carbonic anhydrase inhibitors incorporating an original, new pharmacophore (Articolo in rivista)
- Type
- Label
- Virtual screening-driven identification of human carbonic anhydrase inhibitors incorporating an original, new pharmacophore (Articolo in rivista) (literal)
- Anno
- 2011-01-01T00:00:00+01:00 (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#doi
- 10.1016/j.bmcl.2011.02.059 (literal)
- Alternative label
N. Pala, R. Dallocchio, A. Dessì, A. Brancale, F. Carta, S. Ihm, A. Maresca, M. Sechi, C. T. Supuran (2011)
Virtual screening-driven identification of human carbonic anhydrase inhibitors incorporating an original, new pharmacophore
in Bioorganic & medicinal chemistry letters (Print); Elsevier Ltd, Oxford (Regno Unito)
(literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
- N. Pala, R. Dallocchio, A. Dessì, A. Brancale, F. Carta, S. Ihm, A. Maresca, M. Sechi, C. T. Supuran (literal)
- Pagina inizio
- Pagina fine
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
- Rivista
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#pagineTotali
- Note
- ISI Web of Science (WOS) (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
- Università di Sassari, University of Wales, Cardiff , Università di Firenze, CNR (literal)
- Titolo
- Virtual screening-driven identification of human carbonic anhydrase inhibitors incorporating an original, new pharmacophore (literal)
- Abstract
- Combinated ligand- and pharmacophore-based virtual screening approaches were used to discover novel potential pharmacophores acting as carbonic anhydrase (CA, EC 4.2.1.1) inhibitors (CAIs). A free database of commercially available compounds was screened through drug-like filters using a four-point pharmacophore, and followed by docking calculation within the active site of an X-ray structure of isoform CA II.
One compound, bearing a trifluoro-dihydroxy-propanone moiety, showed an interesting, selective inhibitory activity in low micromolar range against this isoform versus CA I. The chemical originality of this new pharmacophore can represent an important bioisosteric alternative to the sulfonamido-based functionalities, thus leading to the development of a new class of CAI (literal)
- Editore
- Prodotto di
- Autore CNR
- Insieme di parole chiave
Incoming links:
- Autore CNR di
- Prodotto
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
- Editore di
- Insieme di parole chiave di